Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 11/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 2/20 | 0.37 |
| ▸ | GABRD | O14764 | 2/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.37 |
| ▸ | GABRE | P78334 | 2/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11859589 | 1.00 | HCAR2 (0.54) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL989416 | 1.00 | HCAR2 (0.54) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Acrylic Acid SCHEMBL28914099 | 0.92 | HCAR2 (0.47) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL9384923 | 0.91 | HCAR2 (0.39) | HCAR2TSHRTP53ALDH1A1KEAP1 | |
| SCHEMBL746755 | 0.91 | HCAR2 (0.39) | HCAR2TSHRTP53ALDH1A1KEAP1 | |
| Methacrylic Acid SCHEMBL28568084 | 0.89 | HCAR2 (0.44) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL8460434 | 0.89 | HCAR2 (0.38) | HCAR2TSHRTP53ALDH1A1KEAP1 | |
| SCHEMBL16681177 | 0.89 | HCAR2 (0.38) | HCAR2TSHRTP53ALDH1A1KEAP1 | |
| SCHEMBL14157639 | 0.89 | HCAR2 (0.38) | HCAR2TSHRTP53ALDH1A1KEAP1 | |
| Acrylic Acid Methyl Ester SCHEMBL28567664 | 0.86 | HCAR2 (0.50) | HCAR2TSHRALDH1A1GAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163687-B2 | Mixture of amine oxide, glycerol ether solvent, chelate compound and cationic polymers; free of anionic surfactants | THE PROCTER & GAMBLE COMPANY (US) | 2012-04-24 | — | — | US | claimed |
| US-20080255018-A1 | Liquid hard surfaces cleaning compositions | THE PROCTER & GAMBLE COMPANY | 2008-10-16 | — | — | US | claimed |
| EP-1927651-A1 | Liquid hard surface cleaning compositions | The Procter and Gamble Company (US) | 2008-06-04 | — | — | EP | claimed |
| WO-2008059453-A1 | LIQUID HARD SURFACES CLEANING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2008-05-22 | — | — | WO | claimed |
| WO-1999060086-A1 | LIQUID ACIDIC HARD SURFACE CLEANING COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-25 | — | — | WO | claimed |
| EP-0957156-A1 | Liquid acidic hard surface cleaning composition | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-17 | — | — | EP | claimed |
| US-20220324908-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | CYTOGEL PHARMA, LLC | 2022-10-13 | — | — | US | disclosed |
| CN-112898497-B | Polylactic acid-based macromonomer and preparation method and application thereof | 华南师范大学 | 2022-04-26 | — | — | CN | disclosed |
| CN-112759721-B | Thermo-sensitive polylactic acid high polymer material and preparation method and application thereof | 华南师范大学 | 2022-03-25 | — | — | CN | disclosed |
| US-20200339628-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | CYTOGEL PHARMA, LLC | 2020-10-29 | — | — | US | disclosed |
| US-20180291060-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | CYTOGEL PHARMA, LLC | 2018-10-11 | — | — | US | disclosed |
| EP-2826786-B1 | Advantageous Salts of MU-Opiate Receptor Peptides | CYTOGEL PHARMA LLC (US) | 2015-09-23 | — | — | EP | disclosed |
| US-20150152137-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | CYTOGEL PHARMA, LLC | 2015-06-04 | — | — | US | disclosed |
| WO-2009076672-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | CYTOGEL, LLC (US) | 2009-06-18 | — | — | WO | disclosed |
| US-5153178-A | Inotropic agent for the heart of a mixture of a glycoside and a protoberberine alkaloid | MAROKO, ROBERT | 1992-10-06 | — | — | US | disclosed |
| US-4761417-A | INOTROPIC AGENTS | MAROKO, ANDREW | 1988-08-02 | — | — | US | disclosed |
| EP-0241618-A2 | Phenyl ethanol amine derivative for use as an oncolytic medicament | ELI LILLY AND COMPANY (US) | 1987-10-21 | — | — | EP | disclosed |
| EP-0108147-A4 | Use of a protoberberine alkaloid and composition containing same. | MAROKO PETER R | 1984-09-13 | — | — | EP | disclosed |
| EP-0108147-A1 | Use of a protoberberine alkaloid and composition containing same. | MAROKO PETER R | 1984-05-16 | — | — | EP | disclosed |
| WO-1983003970-A1 | COMPOUNDS, COMPOSITIONS AND METHOD OF TREATMENT FOR IMPROVING CIRCULATORY PERFORMANCE | MAROKO PETER R | 1983-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200339628-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | OPRM1, OPRL1, OPRK1 | HCAR2 742/4885TSHR 127/4885TP53 3194/4885 |
| US-20150152137-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | OPRM1, OPRL1, OPRK1 | HCAR2 742/4885TSHR 127/4885TP53 3194/4885 |
| US-20220324908-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | OPRM1, OPRL1, OPRK1 | HCAR2 742/4885TSHR 127/4885TP53 3194/4885 |
| US-20180291060-A1 | ADVANTAGEOUS SALTS OF MU-OPIATE RECEPTOR PEPTIDES | OPRM1, OPRL1, OPRK1 | HCAR2 742/4885TSHR 127/4885TP53 3194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.